Skip to main content

Market Overview

Recap: Sol-Gel Technologies Q3 Earnings



Shares of Sol-Gel Technologies (NASDAQ:SLGL) moved higher by 0.1% after the company reported Q3 results.

Quarterly Results

Earnings per share increased 0.00% year over year to ($0.37), which beat the estimate of ($0.46).

Revenue of $2,116,000 decreased by 55.29% from the same period last year, which beat the estimate of $1,820,000.


Earnings guidance hasn't been issued by the company for now.

Revenue guidance hasn't been issued by the company for now.

How To Listen To The Conference Call

Date: Nov 12, 2020

Time: 07:05 AM

ET Webcast URL:


Company's 52-week high was at $21.00

Company's 52-week low was at $5.00

Price action over last quarter: Up 15.90%

Company Description

Sol-Gel Technologies Ltd is a clinical-stage specialty pharmaceutical company. It is engaged in identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The company's product candidate pipeline consists of silica-based microencapsulation technology platform, and several generic product candidates across multiple indications.


Related Articles (SLGL)

View Comments and Join the Discussion!

Posted-In: Earnings News

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at